Literature DB >> 30709747

Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable.

Edward S Kim1, Upal Basu Roy2, Jennifer L Ersek3, Jennifer King4, Robert A Smith5, Nicole Martin2, Renato Martins6, Amy Moore7, Gerard A Silvestri8, James Jett9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30709747     DOI： 10.1016/j.jtho.2019.01.002

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  5 in total

Review 1.  Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment.

Authors:  Martyna Filipska; Rafael Rosell
Journal:  Mol Oncol       Date:  2021-05-26       Impact factor: 6.603

Review 2.  Practical Considerations Relating to Routine Clinical Biomarker Testing for Non-small Cell Lung Cancer: Focus on Testing for RET Fusions.

Authors:  Roy S Herbst; Dara L Aisner; Joshua R Sonett; Andrew T Turk; Joshua L Weintraub; Neal I Lindeman
Journal:  Front Med (Lausanne)       Date:  2021-01-21

3.  Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan.

Authors:  Yasushi Yatabe; Yasumasa Yoshiki; Koichi Matsumura; Kanae Togo; Hironori Kikkawa; Laura Iadeluca; Benjamin Li; Kazuto Nishio
Journal:  JTO Clin Res Rep       Date:  2020-12-29

Review 4.  Plasma Cell-Free DNA Genotyping: From an Emerging Concept to a Standard-of-Care Tool in Metastatic Non-Small Cell Lung Cancer.

Authors:  Jhanelle Gray; Jeffrey C Thompson; Erica L Carpenter; Ehab Elkhouly; Charu Aggarwal
Journal:  Oncologist       Date:  2021-07-26       Impact factor: 5.837

5.  Real-World Management and Outcomes of Crizotinib-Treated ROS1-Rearranged NSCLC: A Retrospective Canadian Cohort.

Authors:  Amanda J W Gibson; Adrian Box; Winson Y Cheung; Michelle L Dean; Anifat A Elegbede; Desiree Hao; Aliyah Pabani; Randeep Sangha; Dafydd Gwyn Bebb
Journal:  Curr Oncol       Date:  2022-03-14       Impact factor: 3.677
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.